How ResMed Turns Health IT Data into a Better Patient Experience
ResMed SaaS Director Sarah Wright presents company’s case study at San Diego’s “10x for Engineers” conference

SAN DIEGO – October 11, 2018 – ResMed (NYSE: RMD, ASX: RMD), a global leader in medical devices and software, today is presenting on how to improve patients’ therapy experience by analyzing and applying the data collected from their devices at the “10x for Engineers” conference in San Diego.

Sarah Wright, ResMed’s SaaS director of Support Services and Solutions Delivery, will show how ResMed securely uses cloud-transferred device data to develop a holistic view of a patient and apply personalized support to help improve long-term usage and health outcomes:

Presentation info

  • Title: “Leveraging Customer Support to Understand User Needs”
  • Time: 9:40–10:10 a.m. PT
  • Location: Hyatt Regency Mission Bay Spa and Marina, San Diego

ResMed has a world-leading 6 million cloud-connected medical devices for remotely monitoring patients with sleep apnea, which have resulted in:

  • Up to 87 percent patient adherence to therapy, when combined with a self-monitoring app; and
  • Nearly 60 percent time saved by clinicians’ on patient management.

See live-tweet highlights from this presentation on ResMed’s Twitter feed.

About ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 6 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.

# # #

MEDIA: Jayme Rubenstein, 858.836.6798, | INVESTORS: Amy Wakeham, 858.836.5000,
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798


Receive ResMed news releases when they publish.


ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages